An Overview on Antiepileptic Drugs
Overview
Authors
Affiliations
Epilepsy is the most common chronic neurological disorder of the brain. For several decades different kinds of medications have been used to treat epilepsy. Even though many surgical advances has been made and implemented, medications remain the basis of treatment. The search for noble antiepileptic drugs (AEDs) with more selective activity and lower toxicity continues to be an area of intensive investigation in medicinal chemistry. Additionally, drug resistance is an important clinical problem in epilepsy and is associated with an increased risk of morbidity and mortality. This review intends to present a comprehensive overview on AED in particular along with discussion on some aspects of associated drug resistance and combination therapy.
Lin C, Ho C, Chen S, Lu Y, Tsai M Front Pharmacol. 2024; 15:1411487.
PMID: 39228521 PMC: 11368862. DOI: 10.3389/fphar.2024.1411487.
Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature.
Rissardo J, Caprara A Medicina (Kaunas). 2023; 59(8).
PMID: 37629678 PMC: 10456719. DOI: 10.3390/medicina59081389.
Taskiran A, Tastemur Y Exp Brain Res. 2021; 239(2):591-599.
PMID: 33385251 DOI: 10.1007/s00221-020-06012-5.
[Improvement of a mouse model of valproic acid-induced autism].
Zheng W, Hu Y, Chen D, Li Y, Wang S Nan Fang Yi Ke Da Xue Xue Bao. 2019; 39(6):718-723.
PMID: 31270052 PMC: 6743909. DOI: 10.12122/j.issn.1673-4254.2019.06.14.
LaRiviere M, Gross R Front Surg. 2016; 3:64.
PMID: 27995127 PMC: 5136731. DOI: 10.3389/fsurg.2016.00064.